Core Viewpoint - The company reported a steady growth in performance for the first half of 2025, with revenue increasing by 18.5% year-on-year and net profit rising by 9.8%, despite fluctuations in profitability due to delivery schedules affecting high-margin businesses [1][2]. Financial Performance - The company achieved a revenue of HKD 10.316 billion for 25H1, with a net profit of HKD 706 million, a gross margin of 9.2%, and a net margin of 6.8% [2]. - The proposed interim dividend is HKD 0.19 per share, with a dividend payout ratio of approximately 19%, an increase from HKD 0.15 per share and a 16% payout ratio in the same period of 2024 [2]. Business Segments - **Tobacco Leaf Imports**: Revenue of HKD 8.399 billion, up 23.5% year-on-year, with a gross margin of 8.18% [2]. - **Tobacco Leaf Exports**: Revenue of HKD 1.156 billion, up 25.9% year-on-year, with a gross margin of 5.46% [2]. - **Cigarette Exports**: Revenue of HKD 552 million, up 0.8% year-on-year, with a gross margin of 25.70% [2]. - **New Tobacco Exports**: Revenue of HKD 15 million, down 66.5% year-on-year, with a gross margin of 5.34% [2]. - **Brazilian Operations**: Revenue of HKD 195 million, down 50.3% year-on-year, with a gross margin of 27.43% [2]. Strategic Outlook - The company is positioned to maintain a stable growth trajectory, supported by strong supply chain management and its unique status as the only enterprise with state-run tobacco import and export qualifications [3].

Core Viewpoint - China Tobacco Hong Kong (06055) experienced a decline of over 7% post-earnings announcement, with a current drop of 6.11% to HKD 35.62, and a trading volume of HKD 208 million [1] Financial Performance - The company reported a mid-year revenue of HKD 10.316 billion, representing a year-on-year increase of 18.52% [1] - Shareholder profit attributable to the company was HKD 706 million, up 9.79% year-on-year [1] - A mid-term dividend of HKD 0.19 per share is proposed [1] Business Segments - The increase in revenue is attributed to significant price hikes in leaf imports and cigarette exports, although the new tobacco export business saw a notable decline in volume and revenue due to regulatory changes and supply chain disruptions in key overseas markets [1] - The gross profit margin and net profit margin for the first half were 9.17% and 7.00%, respectively, reflecting a year-on-year decrease of 1.91 and 0.81 percentage points [1] Cost Structure - The decline in overall gross margin is primarily due to changes in business structure, with the revenue share of the lower-margin leaf import business increasing by 3.26 percentage points to 81.41% [1] - The cost of leaf sourced from CBT has risen more significantly than the price increase, leading to a decrease in the gross margin for leaf imports [1] Strategic Initiatives - The company continues to expand self-operated channels in cigarette exports and is introducing new products to enhance average transaction value, resulting in a faster increase in gross margin [1] - There remains a strong certainty regarding the profitability of the company's internal business operations, with expectations for continued external growth [1]